Souhaitez-vous accéder aux communiqués récents ?

BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for the brain, today announced a multi-year...

Beacon's 86$ million Series B funding will expand its precision medicine platform, unlocking treatments for neurological and psychiatric disease.

 – Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line – – Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP...

Austin, TX, USA, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biofeedback Instrument Market Size, Trends and Insights By Product Type (EMG...

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Monitoring for Neuroscience Research-New GES 500

KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that...

Austin, TX, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-invasive Brain Trauma Monitoring Device Market Size, Trends and Insights By...

– Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs – – Collaboration aims to uncover novel insights into the brain’s functional architecture...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Electroencephalography Biosensor Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape,...

– Comes less than a year after listing on Nasdaq – KENMORE, N.Y., June 23, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial...